Torres Denice 4
4 · Celldex Therapeutics, Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Torres Denice
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-05+33,000→ 33,000 totalExercise: $19.53Exp: 2035-06-05→ Common Stock (33,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]Such option vests in three equal annual installments beginning June 5, 2026.